Europe’s proteomics market is forecasted to reach USD 9.35 billion by 2021, growing at a CAGR of 16.92%.
Proteomics, over the last decade, has gained importance in the field of diagnosis, drug research, and development. It has various applications ranging from identification of proteins to purification and separation of the protein to study the nature and properties. It has vast applications in identifying some protein-related disorders or diseases in the organism. Thus, it is evolving into an important tool in the field of life sciences.
Europe Proteomics Market-Market Dynamics
The report details several factors that drive and restrain the market for proteomics in Europe. Some of these are listed below.
Europe’s proteomics market is driven by:
The market has some restraints like the high cost of equipment and the strict regulatory norms that make approval of the process of proteomic technology costly and lengthy.
In this report, the market is segmented by instrumentation technology, services market, applications, and geography. Instrumentation technology is further segmented into protein microarray, spectroscopy, and chromatography, etc. The services market is segmented into analytical laboratory services and data analysis and maintenance. Proteomics application is segmented into drug discovery, clinical diagnosis, and others. By geography, the market is segmented into the UK, France, Germany, Spain, and Italy.
Microarrays are predicted to be the major contributors, occupying approximately 70% of the biochip market, while services contribute only 15%. Currently, only microarrays provide high-throughput screening in protein-based diagnostics. The UK is the major shareholder, accounting for 60% of the market, followed by Germany and France.
Some of the key players in the market are:
What the Report Offers
Looking to Customize Report?